Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England.

Byrne L, Campbell H, Andrews N, Ribeiro S, Amirthalingam G.

Arch Dis Child. 2018 Mar;103(3):224-229. doi: 10.1136/archdischild-2016-311802. Epub 2017 Aug 16.

PMID:
28814424
2.

Effectiveness of maternal pertussis vaccination in England: an observational study.

Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M.

Lancet. 2014 Oct 25;384(9953):1521-8. doi: 10.1016/S0140-6736(14)60686-3. Epub 2014 Jul 15.

PMID:
25037990
3.

Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.

Kent A, Ladhani SN, Andrews NJ, Matheson M, England A, Miller E, Heath PT; PUNS study group.

Pediatrics. 2016 Jul;138(1). pii: e20153854. doi: 10.1542/peds.2015-3854. Epub 2016 Jun 2.

4.

Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?

Van Bellinghen LA, Dimitroff A, Haberl M, Li X, Manton A, Moeremans K, Demarteau N.

Hum Vaccin Immunother. 2018;14(9):2263-2273. doi: 10.1080/21645515.2018.1474315. Epub 2018 Jun 22.

5.

Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.

van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E.

J Infect. 2016 Jul;73(1):28-37. doi: 10.1016/j.jinf.2016.04.012. Epub 2016 Apr 22.

6.

The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia.

Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, Bulsara M, Effler PV.

Vaccine. 2015 Oct 13;33(42):5654-5661. doi: 10.1016/j.vaccine.2015.08.066. Epub 2015 Aug 29.

PMID:
26320420
7.

A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016.

Bellido-Blasco J, Guiral-Rodrigo S, Míguez-Santiyán A, Salazar-Cifre A, González-Morán F.

Euro Surveill. 2017 Jun 1;22(22). pii: 30545. doi: 10.2807/1560-7917.ES.2017.22.22.30545.

8.

Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.

Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L.

Vaccine. 2012 May 2;30(21):3239-47. doi: 10.1016/j.vaccine.2011.10.089. Epub 2011 Nov 15.

PMID:
22094282
9.

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction.

Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, Andrews N.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243.

10.

Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination programme.

Carlsson RM, von Segebaden K, Bergstrom J, Kling AM, Nilsson L.

Euro Surveill. 2015 Feb 12;20(6). pii: 21032.

11.

A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013.

Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M.

Clin Infect Dis. 2015 Feb 1;60(3):333-7. doi: 10.1093/cid/ciu821. Epub 2014 Oct 19.

PMID:
25332078
12.

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.

Skoff TH, Blain AE, Watt J, Scherzinger K, McMahon M, Zansky SM, Kudish K, Cieslak PR, Lewis M, Shang N, Martin SW.

Clin Infect Dis. 2017 Nov 29;65(12):1977-1983. doi: 10.1093/cid/cix724.

13.

Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants.

Winter K, Cherry JD, Harriman K.

Clin Infect Dis. 2017 Jan 1;64(1):9-14. Epub 2016 Sep 13.

PMID:
27624956
14.

Seroprevalence of Bordetella pertussis among vaccinated and unvaccinated pregnant women and newborn infants in a university hospital of Buenos Aires.

Bosch JJ, Fernández H, Polak FP, Musante G, Libster R, Rocca Rivarola M.

Arch Argent Pediatr. 2017 Aug 1;115(4):311-315. doi: 10.5546/aap.2017.eng.311. English, Spanish.

15.

Pertussis epidemiology prior to the introduction of a maternal vaccination program, Queensland Australia.

McHugh L, Viney KA, Andrews RM, Lambert SB.

Epidemiol Infect. 2018 Jan;146(2):207-217. doi: 10.1017/S0950268817002722. Epub 2017 Dec 6.

PMID:
29208060
16.

Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.

Sobanjo-Ter Meulen A, Duclos P, McIntyre P, Lewis KD, Van Damme P, O'Brien KL, Klugman KP.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S123-S133. Review.

17.

Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies.

Furuta M, Sin J, Ng ESW, Wang K.

BMC Pregnancy Childbirth. 2017 Nov 22;17(1):390. doi: 10.1186/s12884-017-1559-2. Review.

18.

Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.

Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S.

Vaccine. 2018 Mar 27;36(14):1887-1892. doi: 10.1016/j.vaccine.2018.02.047. Epub 2018 Mar 1.

19.

Predictors of coverage of the national maternal pertussis and infant rotavirus vaccination programmes in England.

Byrne L, Ward C, White JM, Amirthalingam G, Edelstein M.

Epidemiol Infect. 2018 Jan;146(2):197-206. doi: 10.1017/S0950268817002497. Epub 2017 Dec 14.

PMID:
29239285
20.

Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program.

Campbell PT, McVernon J, McIntyre P, Geard N.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S213-S220.

Supplemental Content

Support Center